Regenxbio

(NASDAQ) RGNX

Current Price$9.14

Market Cap$470.75M

Since IPO (2015)-70%

5 Year-74%

1 Year-7%

1 Month+6%

Regenxbio Financials at a Glance

Market Cap

$470.75M

Revenue (TTM)

$170.44M

Net Income (TTM)

$193.88M

EPS (TTM)

$-3.75

P/E Ratio

-2.43

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$9.14

Volume

17,546

Open

$9.23

Price

$9.14

Volume

17,546

Open

$9.23

Previous Close

$9.14

Daily Range

$8.98 - $9.47

52-Week Range

$6.89 - $16.19

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$9.14

Volume

17,546

Open

$9.23

Previous Close

$9.14

Daily Range

$8.98 - $9.47

52-Week Range

$6.89 - $16.19

RGNX News

Son holding father's hand at the hospital

Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio

Todd CampbellMay 24, 2019

3 Top Small-Cap Stocks to Buy Right Now

George Budwell, PhDMar 4, 2019

Page 1

RGNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Regenxbio

Industry

Biotechnology

Sector

Health Care

Employees

371

CEO

Curran M. Simpson

Website

www.regenxbio.com

Headquarters

Rockville, MD 20850, US

RGNX Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-95%

Net Income Margin

-1%

Return on Equity

-107%

Return on Capital

-48%

Return on Assets

-43%

Earnings Yield

-41.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$470.75M

Shares Outstanding

51.62M

Volume

17.55K

Avg. Volume

818.64K

Financials (TTM)

Gross Profit

$150.14M

Operating Income

$161.20M

EBITDA

$145.58M

Operating Cash Flow

$123.96M

Capital Expenditure

$2.41M

Free Cash Flow

$126.38M

Cash & ST Invst.

$230.07M

Total Debt

$260.52M

Regenxbio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$30.34M

+43.0%

Gross Profit

$24.41M

+63.9%

Gross Margin

80.46%

N/A

Market Cap

$470.75M

N/A

Market Cap/Employee

$1.33M

N/A

Employees

353

N/A

Net Income

$67.15M

-31.2%

EBITDA

$63.33M

-67.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$30.45M

-119.9%

Accounts Receivable

$26.38M

+22.3%

Inventory

$0.00

N/A

Long Term Debt

$212.62M

+186.8%

Short Term Debt

$47.90M

+506.1%

Return on Assets

-42.80%

N/A

Return on Invested Capital

-48.13%

N/A

Free Cash Flow

$52.80M

-61.4%

Operating Cash Flow

$52.29M

-65.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$9.09+2.48%

VSTMVerastem, Inc.

VSTMVerastem, Inc.$5.84+6.96%

PRTAProthena Corporation plc

PRTAProthena Corporation plc$10.64-3.80%

ABSIAbsci Corporation

ABSIAbsci Corporation$4.92-1.11%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.37+0.54%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

MLTXMoonLake Immunotherapeutics

MLTXMoonLake Immunotherapeutics$16.73+2.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.60+0.05%

NVDANvidia

NVDANvidia$198.61-0.00%

AAPLApple

AAPLApple$280.19+0.03%

TSLATesla

TSLATesla$390.97+0.02%

NOKNokia

NOKNokia$13.30+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.46+0.02%

AMZNAmazon

AMZNAmazon$268.36+0.01%

Questions About RGNX

What is the current price of Regenxbio?

Regenxbio is trading at $9.14 per share.

What is the 52-week range for Regenxbio?

Over the past 52 weeks, Regenxbio has traded between $6.89 and $16.19.

How much debt does Regenxbio have?

As of the most recent reporting period, Regenxbio reported total debt of $260.52M.

How much cash does Regenxbio have on hand?

Regenxbio reported $34.47M in cash and cash equivalents in its most recent financial results.

What is Regenxbio’s dividend yield?

Regenxbio does not currently have a dividend yield.

Regenxbio

Regenxbio Financials at a Glance

RGNX News

Does an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?

3 Small-Cap Medical Stocks With Big Momentum

Why Regenxbio Stock Is Way Up Today

Big Pharma Has Mad Love For These 2 Biotechs

3 Blindness-Fighting Biotech Stocks That Could Surge This Week

3 Top Biotech Stocks to Buy Right Now

Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio

3 Top Small-Cap Stocks to Buy Right Now

RGNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Regenxbio

RGNX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Regenxbio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RGNX

What is the current price of Regenxbio?

What is the 52-week range for Regenxbio?

How much debt does Regenxbio have?

How much cash does Regenxbio have on hand?

What is Regenxbio’s dividend yield?

Premium Investing Services